Abstract:This longitudinal MRI study aims to validate rsfMRI as a biomarker of EAE disease progression. The whole‐brain functional connectivity with the cerebellum was shown to be early‐phase hyperconnected and late‐phase significantly decreased, and there was a negative correlation between the number of late‐phase activated areas and the disease severity. Multiple sclerosis (MS) is an autoimmune degenerative disease targeting white matter in the central nervous system. The most common animal model that mimics MS is experimental autoimmune encephalomyelitis (EAE) and it plays a crucial role in pharmacological research, from the identification of a therapeutic target to the in vivo validation of efficacy. Magnetic resonance imaging (MRI) is largely used to detect MS lesions, and resting‐state functional MRI (rsfMRI) to investigate alterations in the brain functional connectivity (FC). MRI was mainly used in EAE studies to detect lesions in the spinal cord and brain. The current longitudinal MRI study aims to validate rsfMRI as a biomarker of the disease progression in the myelin oligodendrocyte glycoprotein 35–55 induced EAE animal model of MS. MR images were acquired 14, 25, and 50 days postimmunization. Seed‐based analysis was used to investigate the whole‐brain FC with some predefined areas, such as the thalamic regions, cerebellum, motor and somatosensory cortex. When compared with the control group, the EAE group exhibited a slightly altered FC and a decreasing trend in the total number of activated voxels along the disease progression. The most interesting result regards the whole‐brain FC with the cerebellum. A hyperconnectivity behavior was found at an early phase and a significant reduced connectivity at a late phase. Moreover, we found a negative correlation between the total number of activated voxels during the late phase and the cumulative disease index. The results obtained provide a clinically relevant experimental platform that may be pivotal for the elucidation of the key mechanisms of accumulation of irreversible disability, as well as the development of innovative therapies for MS. Moreover, the negative correlation between the disease severity and the size of the activated area suggests a possible research pathway to follow for the resolution of the clinico‐radiological paradox.

X-ray Phase Contrast Tomography to assess the sequential evolution of multi-organ damage in an animal model of multiple sclerosis

Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis

Synchrotron radiation microtomography of brain hemisphere and spinal cord of a mouse model of multiple sclerosis revealed a correlation between capillary dilation and clinical score

Resting‐state functional magnetic resonance imaging reveals functional connectivity alteration in the experimental autoimmune encephalomyelitis model of multiple sclerosis

Multimodal Coherent Anti-Stokes Raman Scattering Microscopy Reveals Microglia-Associated Myelin and Axonal Dysfunction in Multiple Sclerosis-Like Lesions in Mice.

Characterization of pathological stages in a mouse model of progressive multiple sclerosis

Simultaneous submicrometric 3D imaging of the micro-vascular network and the neuronal system in a mouse spinal cord

Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.

Development of a novel, non-invasive and whole brain biomarker of demyelination in a mouse model of multiple sclerosis

Assessing disease progression and treatment response in progressive multiple sclerosis

Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology

Diffusion Kurtosis Imaging maps neural damage in the EAE model of multiple sclerosis

Advances in brain imaging in multiple sclerosis

A translational MRI approach to validate acute axonal damage detection as an early event in multiple sclerosis

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis

Profiling blood-based brain biomarkers and cytokines in experimental autoimmune encephalomyelitis model of multiple sclerosis using single-molecule array technology

Longitudinal Imaging Biomarkers Correlate with Progressive Motor Deficit in the Mouse Model of Charlevoix‐Saguenay Ataxia

Multiple sclerosis animal models: a clinical and histopathological perspective

Ultrahigh-resolution MRI Reveals Extensive Cortical Demyelination in a Nonhuman Primate Model of Multiple Sclerosis

3-Dimensional Immunostaining and Automated Deep-Learning Based Analysis of Nerve Degeneration

Predicting PET-derived myelin content from multisequence MRI for individual longitudinal analysis in multiple sclerosis